Federal contractor · LONDON

KINIKSA PHARMACEUTICALS (UK), LTD.

KINIKSA PHARMACEUTICALS (UK), LTD. received $362.3K in federal contract obligations in FY2026, on 7 awards (+2.1% vs FY2025). Since FY2022: $1.7M. Its largest customer was Department of Veterans Affairs ($362.3K).

Obligations · FY2026
$362.3K
New awards
7
Sole-source
0.0%
Single offer
100%
UEI
HBHWNLNMHSV5
Parent company
KINIKSA PHARMACEUTICALS LTD
Other than small businessForeign-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 317.9KFY2022
  2. 175.7KFY2023
  3. 527KFY2024
  4. 355KFY2025
  5. 362.3KFY2026

Top buying agencies

Obligations in FY2026.

  1. Department of Veterans Affairs$362.3K100%
    7 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Health & medical$362.3K100%

Where the work was performed

  1. Franklin County, OH$220.2K61%
  2. Abroad$168.3K46%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $362.3K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.7% · $362.3K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. BULK - ARCALYST 220MG VIL$220.2K
    Department of Veterans Affairs· Franklin County, OH· Health & medical· Oct 31, 2025 – Feb 18, 2026· 36C26026F0076
  2. RILONACEPT (ARCALYST) 220MG/VIL INJ$170.1K
    Department of Veterans Affairs· King County, WA· Health & medical· May 31, 2023 – Nov 19, 2025· 36C26023F0351
  3. ARCALYST 220 MG$34K
    Department of Veterans Affairs· Health & medical· May 21, 2026 – May 21, 2026· 36C24526N0595
  4. ARCALYST 200 MG$34K
    Department of Veterans Affairs· Health & medical· Mar 18, 2026 – Mar 18, 2026· 36C24526N0418
  5. ARCALYST 220 MG$34K
    Department of Veterans Affairs· Health & medical· Jul 13, 2026 – Jul 13, 2026· 36C24526N0731
  6. ARCALYST 200 MG$34K
    Department of Veterans Affairs· Health & medical· Jan 31, 2026 – Jan 31, 2026· 36C24526N0294
  7. ARCALYST 200 MG$32.2K
    Department of Veterans Affairs· Health & medical· Dec 22, 2025 – Dec 22, 2025· 36C24526N0196

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. GUARDIAN PHARMACY OF INDIANAPOLIS NUCLEAR, LLC$1M+25% in FY2026
    INDIANAPOLIS, IN · 78% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
  2. ACORDA THERAPEUTICS, INC.$938.1K
    PEARL RIVER, NY · 75% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing
  3. HOT SHOTS NM LLC$1M−25% in FY2026
    DAVENPORT, IA · 78% of this company's obligations are in markets they both serveVeterans Affairs · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.